1. Greece Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Athens Medical C.S.A.

Athens Medical C.S.A.

IATR.AT
Athens Medical C.S.A.GR flagAthens Stock Exchange
1.80
EUR
+0.01
- -
155.69MMarket Cap
Athens Medical C.S.A.
IATR.AT
(Athens Stock Exchange)

Recent

price

1.80

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.69
2.52
2.65
1.64
1.72
1.82
1.93
1.95
2.11
2.27
2.16
2.61
2.69
2.98
3.11
3.18
1.82
Revenue per Share
-0.15
-0.22
-0.09
-0.45
-0.21
-0.18
0.04
0.03
0.12
0.09
0.05
0.17
0.08
0.09
0.02
-0.05
-0.18
Basic EPS, GAAP
-0.31
0.07
0.54
-0.42
0.04
0.15
0.11
-0.02
0.23
0.18
0.38
0.05
-0.18
0.04
0.23
-0.14
0.15
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.02
- -
- -
Dividend per Share
0.65
0.48
0.37
0.35
0.41
0.24
0.26
0.29
0.39
0.47
0.57
0.74
0.81
0.91
0.91
0.85
0.24
Book Value per Share
1.78
1.63
1.52
1.07
0.85
0.67
0.7
0.73
0.82
0.9
0.99
1.16
1.18
1.22
1.18
1.11
0.67
Tangible Book Value per Share
87
87
87
87
87
87
87
87
87
87
87
87
87
87
87
87
87
Basic Weighted Avg Shares
233
219
230
142
149
158
167
169
183
197
188
226
233
258
270
276
158
Sales/Revenue/Turnover
-2.16
-2.68
6.68
-16.7
-6.46
-5.17
6.86
5.94
7.29
6.94
3.85
9.12
7.14
8.03
4.45
1.41
-8.44
Operating Margin (%)
12
14
11
9
9
9
8
9
8
11
12
13
14
15
17
19
9
Depreciation Expense
-13
-19
-8
-39
-19
-16
3
3
11
8
4
15
7
8
2
-5
-16
Net Income, GAAP
- -
- -
- -
- -
- -
- -
47.82
53.67
- -
28.79
32.79
21.51
35.44
40.44
58.08
- -
- -
Effective Tax Rate (%)
-5.73
-8.75
-3.42
-27.16
-12.47
-9.98
2.07
1.55
5.89
3.85
2.09
6.66
2.93
3.13
0.66
-1.69
-9.98
Profit Margin (%)
-89
-94
50
-132
-143
-147
-137
-129
-13
-125
-70
28
14
-3
-39
-68
-147
Working Capital
4
3
148
- -
- -
- -
- -
- -
111
11
40
129
121
102
84
76
- -
LT Debt
157
142
132
93
74
59
61
63
72
79
87
102
103
109
109
104
59
Total Equity
- -
- -
- -
- -
- -
- -
3.71
2.75
- -
5.65
2.47
7.52
5.16
5.8
2.3
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
4.56
3.64
- -
6.96
4.22
9.65
5.45
6
2.66
- -
- -
Return on Capital (%)
-20.43
-39.18
-21.51
-124.78
-56.36
-55.85
15.92
10.96
36.62
20.32
8.71
26.56
10.15
10.83
2.26
-6.13
-55.85
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
ST Debt
152
151
149
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
87
87
87
Market Capitalization
66
60
53

Working Capital

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
Total Current Assets
132
130
124
Cash, Cash Equivalents & STI
4
3
10
Accounts Receivable, Net
88
85
78
Inventories
4
5
5
Total Current Liabilities
276
278
271
Payables & Accruals
- -
- -
- -
ST Debt
152
151
149
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.05%
3.91%
-4.37%
Free Cash Flow
-185.77%
-79.73%
-159.7%
Net Income, GAAP
-10.77%
-38.68%
-362.51%
Sales/Revenue/Turnover
5.91%
8.23%
2.19%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
258
2024
- -
- -
- -
- -
270
2025
- -
- -
- -
- -
276

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.09
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
-0.05

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
- -
Similar Companies
Jiangxi Rimag Group Co., Ltd. (2522.HK)
Talkspace, Inc. (TALK)
Raffles Medical Group Ltd (RAFLF)
Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ)
Kindstar Globalgene Technology, Inc. (9960.HK)
Clariane SE (0OPS.L)
Business
Athens Medical C.S.A. (IATR.AT), operating as Athens Medical Group, provides integrated primary and secondary healthcare services through a network of eight hospitals in Greece equipped with 1,200 beds, 2,800 affiliated physicians, and 3,000 employees; core offerings encompass advanced diagnosis and treatment in interventional cardiology, electrophysiology, pediatric cardiology, cardiac surgery, robotic surgery in general, gynecologic, and urology fields, neuro- and spine surgery, oncology including prostate, bladder, kidney, and testicular cancer, orthopedics covering foot and ankle, hand and wrist, hip, knee, shoulder, and spine conditions as well as sports injuries, plastic and reconstructive surgeries for face, body, breast, obesity, scars, and sex reassignment, bariatric procedures such as gastric banding, sleeve gastrectomy, and biliopancreatic diversion, alongside management of preventive, lifestyle-related, and chronic diseases like diabetes, endocrinology, heart failure, hypertension, pain, respiratory issues, stroke, and thyroid disorders. The company, founded in 1984 and headquartered at 5-7 Distomou Street, Marousi, Greece, serves patients domestically and internationally with a patient-centered approach emphasizing multidisciplinary care for critical illnesses and educational programs tied to its clinical practices. Recent developments include changes to the board of directors and senior management composition following the 2025 annual general meeting in July, appointment of audit committee members and special negotiators in 2025, and release of the consolidated interim financial report for the first half of 2025 in September.